The Minister of Health Fahd Al-Jalajel, announced yesterday the health plans success for this year's Hajj 1443 AH (2022), citing that it is free from disease outbreaks or other effects on public health.
In a statement to Saudi Press Agency on July 11, 2022, the Minister of Health said that “in light of the great support of the Custodian of the Two Holy Mosques and HRH the Crown Prince, I am pleased to announce the success of Hajj health plans for this year 1443 H.”
Hajj 2022 Health Plans Were Successful
Nipah Vaccine Candidate Gains U.S. NIH Pandemic Preparedness Support
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) announced yesterday that it launched a phase 1 clinical study evaluating an investigational messenger RNA (mRNA) vaccine to prevent infection with the Nipah virus.
The mRNA-1215 vaccine candidate is manufactured by Moderna, Inc. and was developed in collaboration with NIAID’s Vaccine Research Center.
mRNA-1215 will be tested in a dose-escalation clinical trial to evaluate its safety, tolerability, and ability to generate an immune response in 40 healthy adults in Maryland.
Physical Activity in Children Dropped During the Pandemic
Findings show 17-minute drop in moderate-to-vigorous physical activity based on global systematic literature review
Biden Administration May Back Second Booster Shots for All Adults
Expanding eligibility requirements for a fourth dose of the vaccine would require regulatory approval
Infant Hospitalization for COVID-19 Reduced With Maternal Vaccination
Effectiveness of maternal vaccination against COVID-19 hospitalization in infants 80 percent during delta, 38 percent during omicron